Nutanix founder raises $44M for SciFin, AI sales platform still seeking customers

Mohit Aron (Nutanix, Cohesity) emerged from stealth with $44 million in seed funding for SciFin, a sales intelligence platform that promises to fix forecast accuracy and reduce admin work. No customers, pricing, or ANZ presence disclosed yet.

Nutanix founder raises $44M for SciFin, AI sales platform still seeking customers

The Numbers

$44 million in seed funding, announced 1 September 2026. Co-led by Altimeter and Madrona. Foundation Capital, S32, and Zetta Ventures participated.

Founder: Mohit Aron, who co-founded Nutanix and founded Cohesity. Now CEO of SciFin, founded 2024.

What it does: Sales intelligence platform that consolidates CRM, call recordings, Slack, and other GTM tools into one continuously updated view. The AI companion, Pixie, answers questions, flags deal risk, and generates reports.

Who it is for: Mid-market and enterprise sales teams. CROs tired of forecast calls based on rep opinion. RevOps teams rebuilding the same reports every week. AEs losing selling time to CRM updates.

What we do not know: Customer count. Pricing. Revenue. Valuation. Headcount. No disclosed CRO or VP Sales. No ANZ office, customers, or local market strategy.

The Honest Assessment

Aron has credibility. He has run revenue organisations at scale and knows the forecast problem from the CRO chair, not from user interviews. The pitch is sharp: maintain context continuously, then put AI on top of accurate data. That ordering matters, because most revenue intelligence tools produce confident answers from stale CRM data.

The category is brutal. Gong, Clari, Salesforce, and HubSpot already own pieces of this territory. Every CRO has been burned by a tool that promised one true view of the pipeline. SciFin's distinction, maintained context versus aggregated records, has to survive contact with genuinely messy enterprise data.

$44 million of seed capital buys time and talent. It also sets expectations very few seed companies meet. No customers means no proof the product works at scale. No pricing means sales teams cannot budget for it yet. No ANZ presence means local adoption is speculative.

What It Means for Sales Teams

If SciFin delivers, the value is clear seat by seat. Sales leaders get early warning on slipping deals. RevOps stops manual reporting. Reps get current deal context without digging through Slack and call transcripts. The company claims Pixie works in chat, voice, email, Slack, Teams, and WhatsApp, which matters if it actually reduces context switching.

The risk is execution. Revenue intelligence is a graveyard of good demos. Aron's track record buys attention, but sales teams need customers, pricing, and proof before this moves from interesting to actionable.

Worth watching. Too early to bet on.